Your session is about to expire
← Back to Search
Episiotomy Scar Massage for Postpartum Pelvic Health (EPIS Trial)
N/A
Recruiting
Led By Erin Brennand, MD, MSc
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
6-10 weeks postpartum after vaginal delivery with episiotomy
Age ≥18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
EPIS Trial Summary
This trial will examine if a larger RCT studying the effects of self-scar tissue massage of episiotomy scar tissue on pelvic health outcomes is possible.
Who is the study for?
This trial is for first-time mothers over 18, within 6-10 weeks postpartum after a vaginal delivery with episiotomy. They must have healed scars as confirmed by their doctor and be able to understand English well enough to follow an instructional video and fill out questionnaires.Check my eligibility
What is being tested?
The study tests if self-scar tissue massage on the perineal area can improve pelvic health in new moms. Participants will either perform self-massage following an instructional video or receive routine care without massage, to compare outcomes using pelvic health questionnaires.See study design
What are the potential side effects?
Since this intervention involves non-invasive self-massage, side effects are expected to be minimal but may include discomfort or pain at the scar site during or after performing the massage.
EPIS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 6-10 weeks postpartum after a vaginal delivery with an episiotomy.
Select...
I am 18 years old or older.
EPIS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Pelvic Floor Distress Inventory (PFDI-20) Outcome Measures with missing data
Number of The Carol Scale with missing data
Number of participants to complete self-scar massage protocol as intended
+2 moreEPIS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Episiotomy and Vaginal/Perineal Tear Self-Scar MassageExperimental Treatment1 Intervention
This Arm will be instructed in and perform self-scar massage to their pelvic floor scar tissue.
Group II: Standard Postnatal CareActive Control1 Intervention
This Arm will not be instructed in or perform self-scar massage to their pelvic floor scar tissue.
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
792 Previous Clinical Trials
869,024 Total Patients Enrolled
Alberta Health servicesOTHER
158 Previous Clinical Trials
649,536 Total Patients Enrolled
Alberta Innovates Health SolutionsOTHER
53 Previous Clinical Trials
94,295 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 6-10 weeks postpartum after a vaginal delivery with an episiotomy.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Episiotomy and Vaginal/Perineal Tear Self-Scar Massage
- Group 2: Standard Postnatal Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the enrollment for this research protocol still open to participants?
"According to clinicaltrials.gov, this trial has ceased participant recruitment since June 8th 2023 - the date of its last update after its initial posting on July 1st, 2023. Fortunately, 36 other studies are still actively enrolling patients presently."
Answered by AI
Share this study with friends
Copy Link
Messenger